Science and Development Network
News, views and information about science, technology and the developing world
Source: The Lancet
16 July 2004 | EN
Recently, the United States ended its rotavirus vaccination programme amid fears over side effects — yet trials of the vaccine are being introduced in developing countries. The virus is one of the most common causes of infant diarrhoea.
In this letter, Dherain Narula and colleagues from St. Stephen's hospital in Delhi, India, argue that in developing countries, trials of the vaccine are unethical. They say such trials counter the Helsinki Declaration — which suggests they should only be carried out in populations set to use the drug — because poorer countries simply cannot afford the vaccine.
Urging trials in the developing world will, the authors say, force people in these countries to act as guinea pigs for the industrialised world.
Link to full letter by Dherain Narula et al in The Lancet
Reference: The Lancet 364, 245 (2004)
Our blog, by SciDev.Net columnist Priya Shetty, will fill you in, as will our interview with the Global Forum's Gill Samuels
Everything a journalist needs to know about the December climate change talks
Countries must cooperate to develop clean technologies. Joint technology innovation centres can help
Will USAID’s likely new chief switch the focus from shipping food to growing it?
Policymakers must improve water storage to help developing countries adapt to climate change
Add your comment
All comments are subject to approval and we reserve the right to edit comments containing inappropriate/unsuitable language. SciDev.Net holds copyright for all material posted on the website. Please see terms of use for further details.
You need to be signed in to post a comment or to email a consenting comment author. Please sign in or sign up.